Cervicitis by Iontophoresis

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05564299` - Rapid Diagnostic Assay for Gonorrhea and Chlamydia	N/A
Terminated	`NCT01072136` - Empiric Therapy of Mucopurulent Cervicitis (MPC)	Phase 3
Recruiting	`NCT01661985` - Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced	Phase 4
Completed	`NCT04809727` - Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT05564299 - Rapid Diagnostic Assay for Gonorrhea and Chlamydia

N/A

Terminated

NCT01072136 - Empiric Therapy of Mucopurulent Cervicitis (MPC)

Phase 3

Recruiting

NCT01661985 - Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced

Phase 4

Completed

NCT04809727 - Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05675293
Study type	Interventional
Source	October 6 University
Contact	MARIAM HELMY, DEMONSTRATOR
Phone	01129985772
Email	MARIAMHELMYMHR@GMAIL.COM
Status	Not yet recruiting
Phase	Early Phase 1
Start date	January 15, 2023
Completion date	February 2023

Cervicitis by Iontophoresis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms